Blackline Inc.(BL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BL Blackline Inc.

未开盘 08-27 16:00:00 EDT

49.95

-0.30

-0.60%

盘后49.95

+0.000.00%

17:57 EDT

最高50.43	最低49.84	成交量57.95万
今开49.98	昨收50.25	日振幅1.17%
总市值31.06亿	流通市值25.83亿	总股本6,218万
成交额2,903万	换手率1.12%	流通股本5,172万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BL","market":"US","secType":"STK","nameCN":"Blackline Inc.","latestPrice":49.95,"timestamp":1724788800000,"preClose":50.25,"halted":0,"volume":579470,"hourTrading":{"tag":"盘后","latestPrice":49.95,"preClose":49.95,"latestTime":"17:57 EDT","volume":90489,"amount":4519928.39,"timestamp":1724795867488},"delay":0,"floatShares":51715251,"shares":62175084,"eps":0.900487,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.3,"latestTime":"08-27 16:00:00 EDT","open":49.98,"high":50.43,"low":49.84,"amount":29034309.5818,"amplitude":0.011741,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.900487,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724832000000},"adr":0,"listingDate":1477627200000,"adjPreClose":50.25,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":49.95,"preClose":49.95,"latestTime":"17:57 EDT","volume":90489,"amount":4519928.39,"timestamp":1724795867488},"volumeRatio":0.661113,"impliedVol":0.3456,"impliedVolPercentile":0.0675},"requestUrl":"/m/hq/s/BL","defaultTab":"news","newsList":[{"id":"2460879692","title":"百利天恒(688506.SH)：BL-B01D1(EGFR×HER3-ADC)用于复发性小细胞肺癌III期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2460879692","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460879692?lang=zh_cn&edition=full","pubTime":"2024-08-18 15:33","pubTimestamp":1723966422,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒(688506.SH)公告，公司自主研发的创新生物药注射用BL-B01D1(EGFR×HER3-ADC)单药用于既往含铂化疗及抗PD-1/PD-L1单抗治疗失败的复发性小细胞肺癌的III期临床试验已于近日完成首例受试者入组。公告显示，BL-B01D1是公司自主研发的全球独家处于临床试验阶段的可同时靶向EGFR和HER3的双抗ADC药物。近日，BL-B01D1单药治疗既往含铂化疗及抗PD-1/PD-L1单抗治疗失败的复发性小细胞肺癌的临床研究已进入III期临床试验阶段并完成首例受试者入组。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1165873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK4080","688506","BK4134","BK1576","LU0757428866.USD","III","BL","BK4023","BK0239","BK1141","LU1815336091.USD","03347","BK4231","ADC"],"gpt_icon":0},{"id":"2459517099","title":"激进投资者 Jana 第二季度增持 BlackLine Systems 股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2459517099","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459517099?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:15","pubTimestamp":1723644944,"startTime":"0","endTime":"0","summary":"    路透纽约8月14日 - 根据周三提交的一份监管文件，激进投资者 Jana Partners 在第二季度增持了美国企业软件公司 BlackLine Systems    的股份。文件显示，截至6月30日，Jana持有115万股，持股比例接近2%。文件显示，Jana持有少量Fortrea Holdings   的股份，在该季度末持有69万股。自从大约两年前 Jana 首次与该公司合作以来，其股价回报率约为 300%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","FYBR","LU0053671581.USD","BK4082","BK4198","BK4115","QDEL","BK4097","LU1878469433.USD","LU0128526141.USD","LU1815336091.USD","FRPT","LU1941712348.USD","BL","LU0757428866.USD","BK4121","LU1941712264.USD","BK4023","BK4212","RPD","FTRE","LU0266013472.USD"],"gpt_icon":0},{"id":"2458380697","title":"Blackline, Inc.2024财年第二财季实现净利润76.69百万美元，同比增加148.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458380697","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458380697?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:18","pubTimestamp":1723393136,"startTime":"0","endTime":"0","summary":"8月12日，Blackline, Inc.公布财报，公告显示公司2024财年第二财季净利润为76.69百万美元，同比增加148.59%；其中营业收入为1.61亿美元，同比增加11.03%，每股基本收益为1.24美元。从资产负债表来看，Blackline, Inc.总负债15.33亿美元，其中短期债务2.54亿美元，资产负债比为1.24，流动比率为1.96。机构评级：截至2024年8月12日，当前有11家机构对Blackline, Inc.目标价做出预测，其中目标均价为55.91美元，其中最低目标价为45.00美元，最高目标价为81.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120019079f222bb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120019079f222bb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BL"],"gpt_icon":0},{"id":"2457844575","title":"Blackline, Inc.盘中异动 股价大涨8.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457844575","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457844575?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:35","pubTimestamp":1723037701,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时35分，Blackline, Inc.股票出现异动，股价急速拉升8.45%。Blackline, Inc.股票所在的软件服务行业中，整体涨幅为1.84%。其相关个股中，T Stamp Inc.、Shopify Inc.、飞塔信息涨幅较大，T Stamp Inc.、Lytus Technologies Holdings Ptv. Ltd.、Microalgo, Inc.较为活跃，换手率分别为270.03%、12.17%、9.80%，振幅较大的相关个股有T Stamp Inc.、大健云仓、声网，振幅分别为29.47%、14.01%、13.00%。Blackline, Inc.公司简介：BlackLine Inc 致力于提供以软件即服务  形式交付的财务会计结算解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072135019f177635&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072135019f177635&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1815336091.USD","BK4023","LU0757428866.USD","BL"],"gpt_icon":0},{"id":"2457882895","title":"美国研究综述-安进、Atkore、Moneylion","url":"https://stock-news.laohu8.com/highlight/detail?id=2457882895","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457882895?lang=zh_cn&edition=full","pubTime":"2024-08-07 16:03","pubTimestamp":1723017814,"startTime":"0","endTime":"0","summary":"    路透8月7日 - 华尔街证券分析师周三调整了对安进、Atkore 和 Moneylion 等几家美国上市公司的评级和目标价。要闻             * 安进公司  ：加拿大皇家银行将其目标价从332美元上调至362美元             * Atkore Inc   ：加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLDR","AVNT","BEAM","BRBR","CERT","IE0002141913.USD","LUMN","BR","AMGN","ADTN","BAX","ALIT","LU1989773731.SGD","ARMK","BK4020","BK4551","AMWL","BL","BK4090","AZTA","BK4149","AEP","BLMN","H","AMH","BK4566","BCC","BWIN","ALAB","CRBU","LU1894683348.USD","ALGT","BBIO","BBWI","CBT","LU0868494708.USD","ADUS","ANAB","AZPN","BRKR","IE00B775SV38.USD","RDDT","IE00B7SZL793.SGD","ATI","LU2098885051.SGD","ACAD","CAT","CAR","XAIR","ATKR"],"gpt_icon":1},{"id":"2456484482","title":"美国研究综述-CH Robinson Worldwide、Dayforce、Entegris","url":"https://stock-news.laohu8.com/highlight/detail?id=2456484482","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456484482?lang=zh_cn&edition=full","pubTime":"2024-08-01 20:58","pubTimestamp":1722517084,"startTime":"0","endTime":"0","summary":"    路透8月1日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 CH Robinson Worldwide、Dayforce 和 Entegris。要闻 * CH Robinson Worldwide Inc   ：摩根大通将其评级从中性上调至增持 * Dayforce Inc   ：Piper Sandler将其评级从中性上调至增持 * Entegris Inc   ：Seaport Research Partners将其评级从中性上调至买入 * Macrogenics Inc   ：BTIG将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVNA","AN","BXC","ATEC","LU0738911758.USD","ALXO","CBRE","CNA","BL","ALL","BLKB","AFL","CPF","LU1974910355.USD","CIVB","DAY","AX","AXP","CAC","CAKE","MSFT","AMWL","LU0345774631.USD","LU2087621335.USD","BK4130","BMRC","COHR","BFH","ANET","AVB","CINF","CHRW","CFG","COF","CWAN","ALKT","LU2211815571.USD","LU1917777945.USD","EA","LU0823417737.USD","CDW","AVDX","CHEF","LU0130102774.USD","BMEA","ALRS","COR","CTSH","ALLY","QCOM","ADP"],"gpt_icon":1},{"id":"2455638865","title":"OneStream IPO：财务软件的未来在这里，股价首日狂涨30%！","url":"https://stock-news.laohu8.com/highlight/detail?id=2455638865","media":"财经自媒体","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455638865?lang=zh_cn&edition=full","pubTime":"2024-07-29 15:42","pubTimestamp":1722238920,"startTime":"0","endTime":"0","summary":"目前，OneStream在全球45多个国家拥有超过1400家客户，全球员工人数达1300人。考虑到其强大的客户留存率，OneStream 吸引新客户的能力尤其令人期待。不过，OneStream的大部分成本用于销售和营销，在2022财年、2023财年和 2024 年第一季度分别占总收入的54.88%、46.89%和43.8%。OneStream预计在可预见的未来将继续产生亏损,因为公司仍在扩大业务规模。以当前每股28美元的股价下，OneStream的市值近65亿美元，企业价值约为60亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-07-29/doc-incfuvpa9021653.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-07-29/doc-incfuvpa9021653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BLSP4452.SGD","GRR","LU1037948541.HKD","SAP","LU2236285917.USD","LU0130102774.USD","LU0965509101.SGD","LU1585245621.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0289960550.SGD","BK4548","IE00BLSP4239.USD","LU1989773731.SGD","LU0208291251.USD","BK4534","LU0889565833.HKD","LU1429558221.USD","ARR","LU1235294995.USD","LU0878866978.SGD","IE00B7SZLL34.SGD","LU0321505439.SGD","LU0068578508.USD","IBM","LU0965509283.SGD","ORCL","OS","LU0321505868.SGD","LU0433182093.SGD","BK4538","BL","IE0009356076.USD","IE00BMPRXR70.SGD","LU0661504455.SGD","LU0082616367.USD","LU1435385759.SGD","WDAY","LU0985489474.SGD","BK4533","IE00BBT3K403.USD","LU1035773651.USD","LU1037948897.HKD","LU1815336091.USD","LU0348723411.USD","LU0648001328.SGD","LU1823568750.SGD","IE0004445239.USD","LU1880398471.USD","LU0868494617.USD"],"gpt_icon":1},{"id":"2450591309","title":"Piper Sandler：维持BlackLine(BL.US)评级，由中性调整至中性评级, 目标价由62.00美元调整至55.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450591309","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450591309?lang=zh_cn&edition=full","pubTime":"2024-07-12 17:10","pubTimestamp":1720775423,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4023","LU0757428866.USD","BL","LU1815336091.USD"],"gpt_icon":0},{"id":"2450695283","title":"百利天恒7月11日晚间公告，公司于近日收到国家药品监督管理局正式批准签发的《药物临床试验批准通知书》，公司自主研发的创新生物药注射用BL-M14D1（ADC）项目治疗晚期实体瘤获得I期临床试验批准通知书。","url":"https://stock-news.laohu8.com/highlight/detail?id=2450695283","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450695283?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:36","pubTimestamp":1720708568,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK1583","BK1576","BK4080","BK1141","159839","03347","BL","BK0239","BK4023","BK4231","688506","LU0757428866.USD","LU1815336091.USD","ADC"],"gpt_icon":0},{"id":"2450796337","title":"【百利天恒(688506.SH)：注射用BL-M14D1(ADC)项目治疗晚期实体瘤获批I期临床试验】智通财经APP讯，百利天恒(688506.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450796337","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450796337?lang=zh_cn&edition=full","pubTime":"2024-07-11 18:45","pubTimestamp":1720694733,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BL","BK0239","03347","LU1815336091.USD","BK4023","ADC.AU","ADC","LU0757428866.USD","BK4080","BK1583","BK4231","BK1141","688506","150272","BK1576","BK7095"],"gpt_icon":0},{"id":"2450337763","title":"百利天恒(688506.SH)：注射用BL-M14D1(ADC)项目治疗晚期实体瘤获批I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2450337763","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450337763?lang=zh_cn&edition=full","pubTime":"2024-07-11 18:45","pubTimestamp":1720694733,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒(688506.SH)发布公告，公司于近日收到国家药品监督管理局(NMPA)正式批准签发的《药物临床试验批准通知书》,公司自主研发的创新生物药BL-M14D1(ADC)的药物临床试验获得批准。BL-M14D1是与BL-B01D1出自同一小分子技术平台、与BL-B01D1共享同一“连接子+毒素”平台的ADC药物，其适应症为晚期实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1149526.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BL","BK4023","BK1583","BK4080","BK4231","LU1815336091.USD","ADC","BK0239","BK1141","688506","LU0757428866.USD","03347"],"gpt_icon":0},{"id":"2450332657","title":"百利天恒称注射用BL-M14D1（ADC）项目治疗晚期实体瘤获得I期临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2450332657","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450332657?lang=zh_cn&edition=full","pubTime":"2024-07-11 18:21","pubTimestamp":1720693312,"startTime":"0","endTime":"0","summary":"百利天恒称注射用BL-M14D1（ADC）项目治疗晚期实体瘤获得I期临床试验批准","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240711:nFWT3J30MW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_zh_live","symbols":["BK4023","BK1576","688506","BK4080","LU0757428866.USD","BK1583","03347","BK4231","BK1141","LU1815336091.USD","BK0239","BL","ADC"],"gpt_icon":0},{"id":"2450221988","title":"【新股消息 | 百利天恒递表港交所 公司BL-B01D1为全球首创进入临床阶段的靶向双抗ADC】智通财经APP获悉，据港交所7月10日披露，四川百利天恒药业股份有限公司向港交所主板提交上市申请，高盛、摩根大通、中信证券为其联席保荐人。","url":"https://stock-news.laohu8.com/highlight/detail?id=2450221988","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450221988?lang=zh_cn&edition=full","pubTime":"2024-07-11 07:04","pubTimestamp":1720652642,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1267930490.SGD","LU2289578879.USD","LU2237443382.USD","LU1328615791.USD","LU0310799852.SGD","BK0196","BK4585","LU1496350502.SGD","LU1119994496.HKD","BK4127","LU1032466523.USD","BK0276","IE00BKVL7J92.USD","LU2237443978.SGD","LU1496350171.SGD","IE0034235188.USD","BK0012","IE00BFXG1179.USD","IE00B775SV38.USD","BK4080","LU1670628061.USD","LU0149725797.USD","BK4023","LU0170899867.USD","BK1147","LU2237443549.SGD","LU1244550221.USD","LU1720050803.USD","LU0211328371.USD","LU1668664300.SGD","LU0971096721.USD","BK0028","LU1064131003.USD","LU0882574139.USD","LU0976567544.SGD","688506","LU1363072403.SGD","LU0320765489.SGD","BL","BK4588","ADC","LU2237443622.USD","06030","LU1244550494.USD","LU1670627923.USD","LU0496365809.HKD","600030","IE00BJTD4V19.USD","LU1084165304.USD","BK4534"],"gpt_icon":0},{"id":"2449777333","title":"【百利天恒(688506.SH)：BL-B01D1(EGFR×HER3双抗ADC)I期临床研究成果在《柳叶刀·肿瘤学》发表】智通财经APP讯，百利天恒(688506.","url":"https://stock-news.laohu8.com/highlight/detail?id=2449777333","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449777333?lang=zh_cn&edition=full","pubTime":"2024-07-08 20:33","pubTimestamp":1720442012,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0757428866.USD","BK4231","ADC","688506","150272","BK4080","BK0239","BK4023","BL","LU1815336091.USD"],"gpt_icon":0},{"id":"2449387774","title":"百利天恒：BL-B01D1(EGFR×HER3双抗ADC)项目研究成果在《柳叶刀·肿瘤学》发布百利天恒公告，公司自主研发的创新生物药BL-B01D1(EGFR×HER3双抗ADC)I期临床研究（首次人体试验）成果近日发表于全球顶级学术期刊《柳叶刀·肿瘤学》","url":"https://stock-news.laohu8.com/highlight/detail?id=2449387774","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449387774?lang=zh_cn&edition=full","pubTime":"2024-07-08 20:07","pubTimestamp":1720440461,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4231","LU1815336091.USD","LU0757428866.USD","BK0239","BL","688506","150272","BK4080","BK4023","ADC"],"gpt_icon":0},{"id":"2448349104","title":"【百利天恒(688506.SH)：BL-B01D1用于局部晚期或转移性三阴乳腺癌III期临床试验完成首例受试者入组】智通财经APP讯，百利天恒(688506.","url":"https://stock-news.laohu8.com/highlight/detail?id=2448349104","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448349104?lang=zh_cn&edition=full","pubTime":"2024-07-03 20:10","pubTimestamp":1720008655,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["III","LU1815336091.USD","BK4134","03347","159839","BK1583","BK4023","BK4231","BK1576","BL","LU0757428866.USD","ADC","BK4080","688506","BK0239","BK1141"],"gpt_icon":0},{"id":"2448109562","title":"百利天恒：BL-B01D1（EGFR×HER3-ADC）用于局部晚期或转移性三阴乳腺癌III期临床试验完成首例受试者入组百利天恒公告，公司自主研发的创新生物药注射用BL-B01D1（EGFR×HER3-ADC）单药用于既往经紫杉烷类治疗失败的不可手术切除的局部晚期或转移性三阴乳腺癌的III期临床试验已于近日完成首例受试者入组。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448109562","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448109562?lang=zh_cn&edition=full","pubTime":"2024-07-03 19:46","pubTimestamp":1720007212,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["ADC","LU0757428866.USD","III","03347","LU1815336091.USD","BK1576","BK1583","BK4134","BK0239","BK4231","688506","BK4080","159839","BK1141","BL","BK4023"],"gpt_icon":0},{"id":"2447166837","title":"内存制造技术再创新，大厂新招数呼之欲出","url":"https://stock-news.laohu8.com/highlight/detail?id=2447166837","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2447166837?lang=zh_cn&edition=full","pubTime":"2024-06-29 09:25","pubTimestamp":1719624309,"startTime":"0","endTime":"0","summary":"在高性能计算系统，特别是AI服务器中，内存的容量和带宽指标越来越重要，因为处理器需要处理巨量数据，传统DRAM已经无法满足需求。目前，HBM是当红炸子鸡。相对于传统DRAM，HBM的制造要复杂很多，它需要将多个DRAM裸片堆叠在一起，这就需要用到较为先进的封装技术了。HBM并不是高性能计算系统用内存的最终形态，从各大存储器厂商的研发方向来看，在存算一体彻底解决“存储墙”问题、相关芯片技术成熟并实现量产之前，3D DRAM将是HBM的继任者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/234303","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4023","BL","LU1815336091.USD","LU0757428866.USD","DRAM"],"gpt_icon":0},{"id":"2446582501","title":"美国研究综述-Alphabet、Equity Residential、Infinera","url":"https://stock-news.laohu8.com/highlight/detail?id=2446582501","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446582501?lang=zh_cn&edition=full","pubTime":"2024-06-28 20:16","pubTimestamp":1719577011,"startTime":"0","endTime":"0","summary":"    路透6月28日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Alphabet、Equity Residential 和 Infinera。要闻 * Alphabet Inc   ：罗森布拉特证券公司将其评级从 \"买入 \"下调至 \"中性\"。* Cincinnati Financial Corp   ：花旗集团将其评级从 \"买入 \"上调至 \"买入 * Equity Residential   ：Piper Sandler将其评级从中性上调至增持 * 英飞朗  ：Stifel将其评级从 \"买入 \"下调至 \"持有 以下是路透周五报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109391861.USD","AOSL","ACCD","APOG","DCTH","CERT","DE","BP","CALC","LU0128525929.USD","ARRY","LU1280957306.USD","DAL","BB","TXG","DAY","LU0708995401.HKD","DLTR","IE00BJTD4N35.SGD","LU0106831901.USD","BL","CMG","CRK","BHF","BKR","DLR","BWIN","AR","LU0494093205.USD","EQH","LU0061475181.USD","CHPT","AFL","AFG","CHWY","T","ALSN","AGCO","ELAN","AMP","AVTR","CHK","CINF","CRBG","CTLT","GOOGL","LU2264538146.SGD","CRL"],"gpt_icon":0},{"id":"2446885253","title":"Blackline, Inc.盘中异动 下午盘股价大涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446885253","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446885253?lang=zh_cn&edition=full","pubTime":"2024-06-25 03:28","pubTimestamp":1719257295,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日03时28分，Blackline, Inc.股票出现波动，股价快速上涨5.37%。Blackline, Inc.股票所在的软件服务行业中，整体跌幅为0.53%。其相关个股中，Microalgo, Inc.、Banzai International Inc C/Wts 14/12/2028 、Arbe Robotics Ltd C/Wts 07/10/2026 涨幅较大，Microalgo, Inc.、Exela Technologies, Inc.、Freight Technologies, Inc.较为活跃，换手率分别为1622.05%、121.02%、25.09%，振幅较大的相关个股有Microalgo, Inc.、Digiasia Corp C/Wts 02/04/2029 、Banzai International Inc C/Wts 14/12/2028 ，振幅分别为235.75%、104.84%、57.52%。Blackline, Inc.公司简介：BlackLine Inc 致力于提供以软件即服务  形式交付的财务会计结算解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625032815968164f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625032815968164f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4023","LU0757428866.USD","BL","LU1815336091.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.blackline.com","stockEarnings":[{"period":"1week","weight":-0.0318},{"period":"1month","weight":0.0445},{"period":"3month","weight":0.0223},{"period":"6month","weight":-0.1195},{"period":"1year","weight":-0.0989},{"period":"ytd","weight":-0.2}],"compareEarnings":[{"period":"1week","weight":0.0051},{"period":"1month","weight":0.0314},{"period":"3month","weight":0.0674},{"period":"6month","weight":0.1053},{"period":"1year","weight":0.2683},{"period":"ytd","weight":0.1815}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BlackLine, Inc.以BlackLine Systems, Inc之名成立于2001年。该公司已经创建了一个全面的基于云计算的软件平台，旨在为所有类型和规模的组织变革和现代化的会计和财务运作。他们的安全可扩展的平台支持关键会计流程，如财务结算，对账，公司间的会计和控制的保证等。通过引入软件来自动化这些流程并使其能够持续运行，他们授权客户提高其财务报告的完整性，提高效率并增强其运营的实时可见性。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.026417},{"month":2,"riseRate":0.5,"avgChangeRate":0.024013},{"month":3,"riseRate":0.25,"avgChangeRate":-0.046622},{"month":4,"riseRate":0.625,"avgChangeRate":0.016571},{"month":5,"riseRate":0.625,"avgChangeRate":0.000833},{"month":6,"riseRate":0.875,"avgChangeRate":0.035947},{"month":7,"riseRate":0.5,"avgChangeRate":0.001384},{"month":8,"riseRate":0.625,"avgChangeRate":0.03376},{"month":9,"riseRate":0.571429,"avgChangeRate":0.003938},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.025077},{"month":11,"riseRate":0.75,"avgChangeRate":0.100615},{"month":12,"riseRate":0.375,"avgChangeRate":-0.008431}],"exchange":"NASDAQ","name":"Blackline Inc.","nameEN":"Blackline Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Blackline Inc.(BL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Blackline Inc.(BL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Blackline Inc.,BL,Blackline Inc.股票,Blackline Inc.股票老虎,Blackline Inc.股票老虎国际,Blackline Inc.行情,Blackline Inc.股票行情,Blackline Inc.股价,Blackline Inc.股市,Blackline Inc.股票价格,Blackline Inc.股票交易,Blackline Inc.股票购买,Blackline Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Blackline Inc.(BL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Blackline Inc.(BL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}